rethinkMushrooms Search
Menu
RethinkMushrooms

Lentinan: Shiitake's Approved Anti-Cancer Compound

Explore mushroom research and guides on lentinan: shiitake's approved anti-cancer compound.

Lentinan: Shiitake's Approved Anti-Cancer Compound

How Lentinan Activates Anti-Cancer Immunity: Step by Step

Lentinan activates macrophages, NK cells, and T cells against tumors through four mechanisms including a 2024 Peyer's patch oral route discovery.

Lentinan: Shiitake's Approved Anti-Cancer Compound

Lentinan Clinical Trials in Gastric Cancer: Results and Outcomes

31 RCTs and 2,729 patients confirm injectable lentinan + chemotherapy improves gastric cancer outcomes (RR=1.48). The Ina 2011 study found 5-year survival of 10% vs 0% for chemo alone.

Lentinan: Shiitake's Approved Anti-Cancer Compound

Lentinan for Cancer: Injectable vs. Oral Forms

Injectable lentinan has 31 RCTs behind it. Oral lentinan has poor systemic bioavailability, but 2024 research shows it activates immunity via a completely different intestinal mechanism.